Literature DB >> 26806540

Activation of transient receptor potential ankyrin 1 by quercetin and its analogs.

Toshiyuki Nakamura1, Noriyuki Miyoshi1, Takeshi Ishii2, Miyu Nishikawa3, Shinichi Ikushiro3, Tatsuo Watanabe1.   

Abstract

The agonistic activity of quercetin and its analogs towards the transient receptor potential ankyrin 1 (TRPA1) has been experimentally investigated. The human TRPA1 was expressed in HEK293T cells using a tetracycline-inducible system. The activation of TRPA1 was evaluated by a fluo-4 fluorescence assay based on calcium sensing. The results of a structure-activity relationship study led to the selection of six flavonoids, all of which activated the TRPA1 channel in a dose-dependent manner. Notably, the activation of TRPA1 by these flavonoid aglycones was completely inhibited by the co-treatment of the HEK293T cells with the TRPA1-specific antagonist, HC-030031. Several flavonoid glycosides and metabolites were also evaluated, but did not activate the TRPA1 except for methylated quercetin. On the other hand, TRPV1 (vanilloid receptor) did not respond to any of the flavonoids evaluated in this study. Therefore, these data suggest that the flavonoids would be promising ligands for the TRPA1.

Entities:  

Keywords:  TRPA1; flavonoid; metabolite; quercetin

Mesh:

Substances:

Year:  2016        PMID: 26806540     DOI: 10.1080/09168451.2015.1132148

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  8 in total

1.  Identification of herbal components as TRPA1 agonists and TRPM8 antagonists.

Authors:  Sho Sanechika; Chika Shimobori; Katsuya Ohbuchi
Journal:  J Nat Med       Date:  2021-04-20       Impact factor: 2.343

2.  Isoliquiritigenin, an active ingredient of Glycyrrhiza, elicits antinociceptive effects via inhibition of Nav channels.

Authors:  Yuichi Miyamura; Suzuro Hitomi; Yuji Omiya; Izumi Ujihara; Shoichiro Kokabu; Yasuhiro Morimoto; Kentaro Ono
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-01-06       Impact factor: 3.000

3.  Quercetin Inhibits Fibroblast Activation and Kidney Fibrosis Involving the Suppression of Mammalian Target of Rapamycin and β-catenin Signaling.

Authors:  Jiafa Ren; Jianzhong Li; Xin Liu; Ye Feng; Yuan Gui; Junwei Yang; Weichun He; Chunsun Dai
Journal:  Sci Rep       Date:  2016-04-07       Impact factor: 4.379

Review 4.  A critical review of cannabis in medicine and dentistry: A look back and the path forward.

Authors:  Ammaar H Abidi; Sahar S Alghamdi; Karen Derefinko
Journal:  Clin Exp Dent Res       Date:  2022-04-01

Review 5.  TRP channels in COVID-19 disease: Potential targets for prevention and treatment.

Authors:  Sahar M Jaffal; Manal A Abbas
Journal:  Chem Biol Interact       Date:  2021-06-21       Impact factor: 5.192

6.  Moringin, A Stable Isothiocyanate from Moringa oleifera, Activates the Somatosensory and Pain Receptor TRPA1 Channel In Vitro.

Authors:  Gigliola Borgonovo; Luciano De Petrocellis; Aniello Schiano Moriello; Simona Bertoli; Alessandro Leone; Alberto Battezzati; Stefania Mazzini; Angela Bassoli
Journal:  Molecules       Date:  2020-02-22       Impact factor: 4.411

Review 7.  Remedia Sternutatoria over the Centuries: TRP Mediation.

Authors:  Lujain Aloum; Eman Alefishat; Janah Shaya; Georg A Petroianu
Journal:  Molecules       Date:  2021-03-15       Impact factor: 4.411

Review 8.  Potential Interplay between Nrf2, TRPA1, and TRPV1 in Nutrients for the Control of COVID-19.

Authors:  Jean Bousquet; Wienczyslawa Czarlewski; Torsten Zuberbier; Joaquim Mullol; Hubert Blain; Jean-Paul Cristol; Rafael De La Torre; Nieves Pizarro Lozano; Vincent Le Moing; Anna Bedbrook; Ioana Agache; Cezmi A Akdis; G Walter Canonica; Alvaro A Cruz; Alessandro Fiocchi; Joao A Fonseca; Susana Fonseca; Bilun Gemicioğlu; Tari Haahtela; Guido Iaccarino; Juan Carlos Ivancevich; Marek Jutel; Ludger Klimek; Helga Kraxner; Piotr Kuna; Désirée E Larenas-Linnemann; Adrian Martineau; Erik Melén; Yoshitaka Okamoto; Nikolaos G Papadopoulos; Oliver Pfaar; Frederico S Regateiro; Jacques Reynes; Yves Rolland; Philip W Rouadi; Boleslaw Samolinski; Aziz Sheikh; Sanna Toppila-Salmi; Arunas Valiulis; Hak-Jong Choi; Hyun Ju Kim; Josep M Anto
Journal:  Int Arch Allergy Immunol       Date:  2021-02-10       Impact factor: 2.749

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.